 |
PDBsum entry 3lw0
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Allosteric igf-1r inhibitors.
|
 |
|
Authors
|
 |
T.Heinrich,
U.Grädler,
H.Böttcher,
A.Blaukat,
A.Shutes.
|
 |
|
Ref.
|
 |
ACS Med Chem Lett, 2010,
1,
199-203.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Targeting allosteric protein sites is a promising approach to interfere
selectively with cellular signaling cascades. We have discovered a novel class
of allosteric insulin-like growth factor-I receptor (IGF-1R) inhibitors.
3-Cyano-1H-indole-7-carboxylic acid
{1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl}amide (10) was found with
nanomolar biochemical, micromolar, cellular IGF-1R activity and no relevant
interference with cellular insulin receptor signaling up to 30 μM. The
allosteric binding site was characterized by X-ray crystallographic studies, and
the structural information was used to explain the unique mode of action of this
new class of inhibitors.
|
 |
|
|
|
|
 |